Idexx Laboratories (IDXX) Research & Development (2009 - 2026)

Idexx Laboratories (IDXX) has reported Research & Development for 18 consecutive years, with $65.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Research & Development rose 11.39% year-over-year to $65.8 million; the TTM figure through Mar 2026 stood at $257.9 million (up 14.02% YoY), while the FY2025 annual figure was $251.2 million, up 14.29% from the prior year.
• Research & Development came in at $65.8 million for Q1 2026 at Idexx Laboratories, down from $66.8 million in the prior quarter.
• The five-year high for Research & Development was $123.2 million in Q2 2022, with the low at $40.2 million in Q1 2022.
• Average Research & Development over 5 years is $57.8 million, with a median of $54.0 million recorded in 2024.
• Across the five-year window, Research & Development jumped 226.87% in 2022 and tumbled 62.26% in 2023, its largest moves.
• Year by year, Research & Development stood at $43.4 million in 2022, then advanced by 19.33% to $51.8 million in 2023, then increased by 11.42% to $57.7 million in 2024, then increased by 15.77% to $66.8 million in 2025, then declined by 1.56% to $65.8 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $65.8 million, $66.8 million, and $63.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.